re: Ann: 25 Per Cent Dose Sales Growth in Sec...
persistentone,
"moogar, at a PE over 40, I am amazed that a 25% growth result didn't send the stock gapping down $2 on the first trade. Are you not aware of the fact that you own something priced for continuous 40% growth? It's expensive"
Not sure how a PE of 40 can be equated to continuous 40% growth but maths was never my strong point.
We invested in the floats of both CSL and COH. To my mind Cochlear is the better comparison with Sirtex and it is informative to look at some of the early PEs of Cochlear. They make the Sirtex 40% look extremely modest, it's many years ago but I seem to remember COH on a PE of 100 at one stage.
Cafa and others are correct, anticipation of another high Q on Q figure and admission to the ASX 200 had seen the SP overshoot a bit.
Just depends if you arte a trader or investor, the trader probably sold and the investor probably bought a few more.
regards, EB
- Forums
- ASX - By Stock
- SRX
- Ann: 25 Per Cent Dose Sales Growth in Second Quar
Ann: 25 Per Cent Dose Sales Growth in Second Quar, page-15
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)